What is the current valuation of the UK medical tourism market?

The market valuation was $681.25 Million in 2024. Read More

What is the projected market size for the UK medical tourism market by 2035?

The projected valuation for 2035 is $2023.45 Million. Read More

What is the expected CAGR for the UK medical tourism market from 2025 to 2035?

The expected CAGR during the forecast period is 10.4%. Read More

Which treatment types are the most lucrative in the UK medical tourism market?

Surgical procedures and cosmetic procedures are among the most lucrative, with valuations of $460.0 Million and $540.0 Million, respectively. Read More

What are the key segments in the UK medical tourism market?

Key segments include treatment type, service type, patient demographics, and funding source. Read More

How do international patients contribute to the UK medical tourism market?

International patients contributed $600.0 Million in 2024, indicating a strong demand for medical services. Read More

What role do key players like Bumrungrad International Hospital play in the market?

Key players such as Bumrungrad International Hospital and Apollo Hospitals are instrumental in shaping the market landscape. Read More

What are the primary funding sources for medical tourism in the UK?

Self-payment and health insurance are primary funding sources, with valuations of $408.45 Million and $612.45 Million, respectively. Read More

How do travel services impact the UK medical tourism market?

Travel services accounted for $245.0 Million in 2024, highlighting their importance in the overall market. Read More

What demographic trends are observed in the UK medical tourism market?

Elderly patients and travelers seeking wellness represent significant demographics, with valuations of $300.0 Million and $240.0 Million, respectively. Read More

UK Medical Tourism Market

ID: MRFR/MED/42413-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

UK Medical Tourism Market Research Report: Size, Share, Trend Analysis By Types Outlook (Orthopedic/Spine Treatments, Oncology/Cancer Treatments, Cosmetic Treatments, Cardiovascular Treatments, Dental Treatments, Fertility/IVF Treatments, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Treatment Type (USD Million)
  1. 4.1.1 Surgical Procedures
  2. 4.1.2 Dental Procedures
  3. 4.1.3 Fertility Treatments
  4. 4.1.4 Cosmetic Procedures
  5. 4.1.5 Weight Loss Procedures
2. 4.2 Pharmaceutical, BY Service Type (USD Million)
  1. 4.2.1 Travel Services
  2. 4.2.2 Accommodation Services
  3. 4.2.3 Medical Services
  4. 4.2.4 Insurance Services
  5. 4.2.5 Wellness Services
3. 4.3 Pharmaceutical, BY Patient Demographics (USD Million)
  1. 4.3.1 Domestic Patients
  2. 4.3.2 International Patients
  3. 4.3.3 Elderly Patients
  4. 4.3.4 Travelers Seeking Wellness
  5. 4.3.5 Patients Seeking Specialized Treatments
4. 4.4 Pharmaceutical, BY Funding Source (USD Million)
  1. 4.4.1 Self-Payment
  2. 4.4.2 Health Insurance
  3. 4.4.3 Government Programs
  4. 4.4.4 Employer-Sponsored Programs
  5. 4.4.5 Medical Credit Financing
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bumrungrad International Hospital (TH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Apollo Hospitals (IN)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Fortis Healthcare (IN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 KPJ Healthcare Berhad (MY)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 NMC Health (AE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bangkok Hospital (TH)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cleveland Clinic (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 MediGence (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Healthbase (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY TREATMENT TYPE
3. 6.3 UK MARKET ANALYSIS BY SERVICE TYPE
4. 6.4 UK MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
5. 6.5 UK MARKET ANALYSIS BY FUNDING SOURCE
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY SERVICE TYPE, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY SERVICE TYPE, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY FUNDING SOURCE, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY FUNDING SOURCE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY SERVICE TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2025-2035 (USD Million)
  4. 7.2.4 BY FUNDING SOURCE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Pharmaceutical Market Segmentation

Pharmaceutical By Treatment Type (USD Million, 2025-2035)

Surgical Procedures
Dental Procedures
Fertility Treatments
Cosmetic Procedures
Weight Loss Procedures

Pharmaceutical By Service Type (USD Million, 2025-2035)

Travel Services
Accommodation Services
Medical Services
Insurance Services
Wellness Services

Pharmaceutical By Patient Demographics (USD Million, 2025-2035)

Domestic Patients
International Patients
Elderly Patients
Travelers Seeking Wellness
Patients Seeking Specialized Treatments

Pharmaceutical By Funding Source (USD Million, 2025-2035)

Self-Payment
Health Insurance
Government Programs
Employer-Sponsored Programs
Medical Credit Financing

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”